Analysis of MRI use in the diagnostic pathway for #BladderCancer. Professor Nicholas James The Institute of Cancer Research joins Ashish Kamat, MD, MBBS MD Anderson Cancer Center to discuss the final #BladderPath trial survival analyses, demonstrating mpMRI introduced upstream of TURBT significantly improves bladder cancer-specific survival with a statistically significant hazard ratio driven entirely by muscle-invasive disease outcomes. #WatchNow on UroToday > bit.ly/4705bJe #ESMO25 | UroToday

Bladder cancer breakthrough as scan could help patients be treated TWICE as fast

Bladder Cancer: how to recognize symptoms and reduce risks

Bladder Cancer Signs and Symptoms